methylphenidate HCl 20 MG 50/50 Release 24HR Extended Release Oral Capsule

RxCUI
1806177
RxNorm name
methylphenidate HCl 20 MG 50/50 Release 24HR Extended Release Oral Capsule
Display name
methylphenidate HCl 20 MG 50/50 Release 24HR Extended Release Oral Capsule
Full name
methylphenidate HCl 20 MG 50/50 Release 24HR Extended Release Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 7 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Methylphenidate Hydrochloride (LA)METHYLPHENIDATE HYDROCHLORIDEMayne Pharmae5db854a-1c77-4faf-9e60-daf9c9b6cfa02025-11-06Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1806177
Methylphenidate HydrochlorideMETHYLPHENIDATE HYDROCHLORIDEGranules Pharmaceuticals Inc.27ea91ad-f64e-43d7-ab10-6f988bca53792025-10-08Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1806177
Methylphenidate Hydrochloride (LA)METHYLPHENIDATE HYDROCHLORIDEDr. Reddy's Laboratories Incd8c14df4-ac05-d69d-9308-58a51d5683292025-09-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1806177
MethylphenidateMETHYLPHENIDATESandoz Inc1f8983ce-71b8-4c62-830d-e4692ddededa2025-09-23Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1806177
Ritalin LAMETHYLPHENIDATE HYDROCHLORIDENovartis Pharmaceuticals Corporationeffd952d-ac94-47bb-b107-589a4934dcca2025-09-23Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1806177
MethylphenidateMETHYLPHENIDATESandoz Inc44386394-d2a3-4483-abe1-6c5c634cc5012025-09-23Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1806177
Methylphenidate Hydrochloride (LA)METHYLPHENIDATE HYDROCHLORIDETeva Pharmaceuticals USA, Inc.034fb7cd-e183-475e-8beb-64fd88facc8f2019-12-31Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1806177

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
effd952d-ac94-47bb-b107-589a4934dccamethylphenidate HCl 20 MG 50/50 Release 24HR Extended Release Oral CapsulePSN36These highlights do not include all the information needed to use RITALIN LA safely and effectively. See full prescribing information for RITALIN LA. RITALIN LA ® (methylphenidate hydrochloride) extended-release capsules for oral use, CII Initial U.S. Approval: 195520250923
effd952d-ac94-47bb-b107-589a4934dcca50/50 Release 24 HR methylphenidate hydrochloride 20 MG Extended Release Oral CapsuleSCD36These highlights do not include all the information needed to use RITALIN LA safely and effectively. See full prescribing information for RITALIN LA. RITALIN LA ® (methylphenidate hydrochloride) extended-release capsules for oral use, CII Initial U.S. Approval: 195520250923
effd952d-ac94-47bb-b107-589a4934dccamethylphenidate HCl 20 MG 50/50 Release 24HR Extended Release Oral CapsuleSY36These highlights do not include all the information needed to use RITALIN LA safely and effectively. See full prescribing information for RITALIN LA. RITALIN LA ® (methylphenidate hydrochloride) extended-release capsules for oral use, CII Initial U.S. Approval: 195520250923
27ea91ad-f64e-43d7-ab10-6f988bca5379methylphenidate HCl 20 MG 50/50 Release 24HR Extended Release Oral CapsuleSY12METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HYDROCHLORIDE extended-release capsules, for oral use, CII Initial U.S. Approval: 195520251008
27ea91ad-f64e-43d7-ab10-6f988bca537950/50 Release 24 HR methylphenidate hydrochloride 20 MG Extended Release Oral CapsuleSCD12METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HYDROCHLORIDE extended-release capsules, for oral use, CII Initial U.S. Approval: 195520251008
27ea91ad-f64e-43d7-ab10-6f988bca5379methylphenidate HCl 20 MG 50/50 Release 24HR Extended Release Oral CapsulePSN12METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HYDROCHLORIDE extended-release capsules, for oral use, CII Initial U.S. Approval: 195520251008
e5db854a-1c77-4faf-9e60-daf9c9b6cfa0methylphenidate HCl 20 MG 50/50 Release 24HR Extended Release Oral CapsulePSN10These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA) safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA). METHYLPHENIDATE HYDROCHLORIDE extended-release capsules (LA) for oral use, CII Initial U.S. Approval: 195520251106
e5db854a-1c77-4faf-9e60-daf9c9b6cfa050/50 Release 24 HR methylphenidate hydrochloride 20 MG Extended Release Oral CapsuleSCD10These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA) safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA). METHYLPHENIDATE HYDROCHLORIDE extended-release capsules (LA) for oral use, CII Initial U.S. Approval: 195520251106
e5db854a-1c77-4faf-9e60-daf9c9b6cfa0methylphenidate HCl 20 MG 50/50 Release 24HR Extended Release Oral CapsuleSY10These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA) safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA). METHYLPHENIDATE HYDROCHLORIDE extended-release capsules (LA) for oral use, CII Initial U.S. Approval: 195520251106
034fb7cd-e183-475e-8beb-64fd88facc8fmethylphenidate HCl 20 MG 50/50 Release 24HR Extended Release Oral CapsuleSY10These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES LA safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES LA . METHYLPHENIDATE HYDROCHLORIDE extended-release capsules for oral use, CII Initial U.S. Approval: 195520191231
034fb7cd-e183-475e-8beb-64fd88facc8f50/50 Release 24 HR methylphenidate hydrochloride 20 MG Extended Release Oral CapsuleSCD10These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES LA safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES LA . METHYLPHENIDATE HYDROCHLORIDE extended-release capsules for oral use, CII Initial U.S. Approval: 195520191231
034fb7cd-e183-475e-8beb-64fd88facc8fmethylphenidate HCl 20 MG 50/50 Release 24HR Extended Release Oral CapsulePSN10These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES LA safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES LA . METHYLPHENIDATE HYDROCHLORIDE extended-release capsules for oral use, CII Initial U.S. Approval: 195520191231
1f8983ce-71b8-4c62-830d-e4692ddededamethylphenidate HCl 20 MG 50/50 Release 24HR Extended Release Oral CapsuleSY8These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HYDROCHLORIDE Extended-Release Capsules for oral use, CII Initial U.S. Approval: 195520250923
1f8983ce-71b8-4c62-830d-e4692ddededa50/50 Release 24 HR methylphenidate hydrochloride 20 MG Extended Release Oral CapsuleSCD8These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HYDROCHLORIDE Extended-Release Capsules for oral use, CII Initial U.S. Approval: 195520250923
1f8983ce-71b8-4c62-830d-e4692ddededamethylphenidate HCl 20 MG 50/50 Release 24HR Extended Release Oral CapsulePSN8These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HYDROCHLORIDE Extended-Release Capsules for oral use, CII Initial U.S. Approval: 195520250923
44386394-d2a3-4483-abe1-6c5c634cc50150/50 Release 24 HR methylphenidate hydrochloride 20 MG Extended Release Oral CapsuleSCD4These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HYDROCHLORIDE Extended-Release Capsules for oral use, CII Initial U.S. Approval: 195520250923
44386394-d2a3-4483-abe1-6c5c634cc501methylphenidate HCl 20 MG 50/50 Release 24HR Extended Release Oral CapsuleSY4These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HYDROCHLORIDE Extended-Release Capsules for oral use, CII Initial U.S. Approval: 195520250923
44386394-d2a3-4483-abe1-6c5c634cc501methylphenidate HCl 20 MG 50/50 Release 24HR Extended Release Oral CapsulePSN4These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HYDROCHLORIDE Extended-Release Capsules for oral use, CII Initial U.S. Approval: 195520250923
d8c14df4-ac05-d69d-9308-58a51d568329methylphenidate HCl 20 MG 50/50 Release 24HR Extended Release Oral CapsuleSY2These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA) safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA). METHYLPHENIDATE HYDROCHLORIDE extended-release capsules (LA) for oral use, CII Initial U.S. Approval: 195520250930
d8c14df4-ac05-d69d-9308-58a51d568329methylphenidate HCl 20 MG 50/50 Release 24HR Extended Release Oral CapsulePSN2These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA) safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA). METHYLPHENIDATE HYDROCHLORIDE extended-release capsules (LA) for oral use, CII Initial U.S. Approval: 195520250930
d8c14df4-ac05-d69d-9308-58a51d56832950/50 Release 24 HR methylphenidate hydrochloride 20 MG Extended Release Oral CapsuleSCD2These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA) safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA). METHYLPHENIDATE HYDROCHLORIDE extended-release capsules (LA) for oral use, CII Initial U.S. Approval: 195520250930